References
- EngelhardtGHommaDSchlegelKUtzmannRSchnitzlerCAnti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal toleranceInflamm Res199544104234338564518
- ElmotasemHChitosan–alginate blend films for the transdermal delivery of meloxicamAsian J Pharm Sci200811229
- IaniskiFRAlvesCBFerreiraCFMeloxicam-loaded nanocapsules as an alternative to improve memory decline in an Alzheimer’s disease model in mice: involvement of Na(+), K(+)-ATPaseMetab Brain Dis201631479380226922073
- LugerPDaneckKEngelWTrummlitzGWagnerKStructure and physicochemical properties of meloxicam, a new NSAIDEur J Pharm Sci199643175187
- AhYCChoiJKChoiYKKiHMBaeJHA novel transdermal patch incorporating meloxicam: in vitro and in vivo characterizationInt J Pharm20103851–2121919833177
- YuanYLiSMMoFKZhongDFInvestigation of microemulsion system for transdermal delivery of meloxicamInt J Pharm20063211–211712316876972
- ChenJGaoYStrategies for meloxicam delivery to and across the skin: a reviewDrug Deliv20162383146315626956920
- FaridMEl-SetouhyDAEl-NabarawiMAEl-BayomiTParticle engineering/different film approaches for earlier absorption of meloxicamDrug Deliv20162372309231725431841
- HorvathTAmbrusRVolgyiGEffect of solubility enhancement on nasal absorption of meloxicamEur J Pharm Sci2016959610227260088
- IurianSTomutaIRusLAchimMLeucutaSEOptimization of the sonication process for meloxicam nanocrystals preparationClujul Med201588336637226609271
- PanSTakebeGSuzukiMNanonization of poorly water-soluble drug clobetasone butyrate by using femtosecond laserOpt Commun2014313152156
- ChenHKhemtongCYangXChangXGaoJNanonization strategies for poorly water-soluble drugsDrug Discov Today2011167–835436020206289
- LiYZhaoXZuYZhangYPreparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenizationInt J Pharm20154901–232433326027492
- SattarAChenDJiangLPreparation, characterization and pharmacokinetics of cyadox nanosuspensionSci Rep201771228928536446
- HuKZhouHLiuYHyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cellsNanoscale20157188607861825898852
- GuoMLawW-CNgCHPreparation of size tunable, glutathione-responsive hyaluronic acid-quantum dot nanohybrids using microemulsion methodSci Adv Mater201572364370
- KarpelRLda Silva LiberatoMCampeiroJDDesign and characterization of crotamine-functionalized gold nanoparticlesColloids Surf B Biointerfaces20181631829268209
- LeeSHJungHKKimTCFacile method for the synthesis of gold nanoparticles using an ion coaterAppl Surf Sci201843410011006
- ChuesiangPSiripatrawanUSanguandeekulRMcLandsboroughLJulian McClementsDOptimization of cinnamon oil nanoemulsions using phase inversion temperature method: impact of oil phase composition and surfactant concentrationJ Colloid Interface Sci201851420821629257975
- FangJNakamuraHMaedaHThe EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Deliv Rev201163313615120441782
- GuoLKangLLiuXA novel nanosuspension of andrographolide: preparation, characterization and passive liver target evaluation in ratsEur J Pharm Sci2017104132228315464
- TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev201163313113520304019
- WangLDuJZhouYWangYSafety of nanosuspensions in drug deliveryNanomedicine201713245546927558350
- YadollahiRVasilevKSimovicSNanosuspension technologies for delivery of poorly soluble drugsJ Nanomater20152015113
- MaedaHMatsumuraYEPR effect based drug design and clinical outlook for enhanced cancer chemotherapyAdv Drug Deliv Rev201163312913020457195
- ChenCHuHQiaoMTumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxelInt J Pharm20154801–211612725615984
- WangZLiZZhangDMiaoLHuangGDevelopment of etoposide-loaded bovine serum albumin nanosuspensions for parenteral deliveryDrug Deliv2015221798524401038
- KayaMMulercikasPSarginIThree-dimensional chitin rings from body segments of a pet diplopod species: characterization and protein interaction studiesMater Sci Eng C Mater Biol Appl20166871672227524072
- KratzFAlbumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticlesJ Control Release2008132317118318582981
- RahimnejadMMJahanshahiMNajafpourGDProduction of biological nanoparticles from bovine serum albumin for drug deliveryAfr J Biotechnol201052019181923
- LedesmaAEChemesDMFríasMdlAGuauque TorresMdPSpectroscopic characterization and docking studies of ZnO nanoparticle modified with BSAAppl Surf Sci2017412177188
- RubinoOPKowalskyRSwarbrickJAlbumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug releasePharm Res1993107105910658378248
- DuTLiuBHouXZhangBDuCCovalent immobilization of glucose oxidase onto Poly(St-GMA-NaSS) monodisperse microspheres via BSA as spacer armAppl Surf Sci20092551879377941
- JadhavPDShimYYReaneyMJSynthesis and characterization of site-selective orbitide-BSA conjugate to produce antibodiesBioconjug Chem201627102346235827626291
- GarciaDRLavignacNPoly(amidoamine)–BSA conjugates synthesised by Michael addition reaction retained enzymatic activityPolym Chem201674772237229
- HanMLiuXGuoYWangYWangXPreparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensionsInt J Pharm20134551–2859223928147
- KimTHJiangHHYounYSPreparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activityInt J Pharm20114031–228529121035530
- GawdeKAKesharwaniPSauSSynthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogueJ Colloid Interface Sci201749629029928236692
- AhujaBKJenaSKPaidiSKBagriSSureshSFormulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspensionInt J Pharm2015478254055225490182
- MouDChenHWanJXuHYangXPotent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubilityInt J Pharm20114131–223724421540090
- ZhaoXWangWZuYPreparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitationDrug Deliv201421646747924479653
- XuYLiuXLianREnhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralizationInt J Pharm20124381–228729522989976
- SadeghiHHajhashemiVMinaiyanMMovahedianATalebiAFurther studies on anti-inflammatory activity of maprotiline in carrageenan-induced paw edema in ratInt Immunopharmacol201315350551023415748
- ElzoghbyAOSamyWMElgindyNAAlbumin-based nanoparticles as potential controlled release drug delivery systemsJ Control Release2012157216818221839127
- ChenHWanJWangYA facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid-base neutralization reactionsNanotechnology2008193737510421832541
- AliHSYorkPBlagdenNPreparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactorsInt J Pharm20093751–210711319481696
- PatravaleVBDateAAKulkarniRMNanosuspensions: a promising drug delivery strategyJ Pharm Pharmacol200456782784015233860
- JensenLGSkautrupFBMullertzAAbrahamssonBRadesTPriemelPAAmorphous is not always better: a dissolution study on solid state forms of carbamazepineInt J Pharm20175221–2747928263832
- SinghSVaidyaYGulatiMBhattacharyaSGargVPandeyNNanosuspension: principles, perspectives and practicesCurr Drug Deliv20161381222124626721266
- GaoLZhangDChenMDrug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery systemJ Nanopart Res2008105845862
- MaedaHNakamuraHFangJThe EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivoAdv Drug Deliv Rev2013651717923088862